Research & Development



  過了楊柳街,曹襄的耳朵里就灌滿了學問。   “你是匈奴人,听說你們喜歡射箭是嗎?”超碰人人最新上线视频   一個美麗的如同妖精一般的胡姬如同蛇一般纏繞上來,曹襄笑道︰“我已經沒有力氣了。”超碰免费   洗漱過後,他就施施然的下了萬花閣。   雲瑯再次定楮看去,忍不住倒吸了一口涼氣,只見在燭光的照耀下,這塊薄薄的玉石中間居然瓖嵌著一朵翠綠色的植物。超碰免费视频caoponAV   阿嬌點點頭道︰“總算是干了一件明白事情!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo